Table 2.
Model name | Variant type | Strain | Phenotype | Inheritance | Syndrome | References |
---|---|---|---|---|---|---|
mgΔ | in frame del 6 kb ins PGKneo |
C57BL/6J | Aortic dilatation, pre weaning lethal | recessive | MFS | Pereira et al. (1997) |
mgR | ins PGKneo | C56BL/6 | Vascular abnormalities, kyphosis, bone overgrowth | recessive | MFS | Pereira et al. (1999) |
mgN | del 700 bp ins PGKneo |
C57BL/6J | Aortic aneurysm, impaired respiratory function, pre weaning lethal | recessive | MFS | Carta et al. (2006) |
mgΔloxPneo | in frame del exons 19–24 ins PGKneo ins 2 × loxP |
C57BL/6 | Vascular abnormalities and skeletal phenotype by 9 months, severe pulmonary alterations by 6 months, ocular abnormalities including ectopia lentis, homozygote lethal pre E13 | dominant | MFS | Lima et al. (2010), de Souza et al. (2019), and Souza et al. (2021) |
129/Sv | Vascular abnormalities, severe pulmonary alterations, skeletal phenotype by 3 months, interindividual variability, homozygote lethal pre E13 | dominant | MFS | |||
Mixed 129/Sv and CD-1 | Sporadic spinal deformities | dominant | ||||
GT-8 | truncation after exon 32 ins GFP | C57BL/6 | Abnormal microfibril morphology, homozygote postnatal lethal P9-P18 | dominant | MFS | Charbonneau et al. (2010a) |
C1041Ga | missense | C57BL/6J | Deterioration of aortic structure with age, skeletal anomalies, widening of airspaces, homozygote postnatal lethal P7-P10 from aortic dissection | dominant | MFS | Judge et al. (2004) |
D1545E | missense | Mixed C57BL/6J and 129/SvEv | Pathological skin fibrosis, homozygote lethal pre E10.5 | dominant | SSS | Gerber et al. (2013) |
W1572C | missense | Mixed C57BL/6J and 129/SvEv | Pathological skin fibrosis, homozygote viable with accelerated skin fibrosis | dominant | SSS | Gerber et al. (2013) |
Tsk | in frame dup 30–40 kb | B10.D2(58N)/Sn | Thick skin, visceral fibrosis, increased skeletal size, homozygote lethal pre E8 | dominant | SSS | Siracusa et al. (1996) |
WMΔ | del exon 10–12 | C57BL/6 | Thick skin, brachydactyly, early reduced long bone growth, homozygote has normal viability | dominant | WMS2 | Sengle et al. (2012) |
H1Δ | del exon 7, first hybrid domain | C57BL/6 | Grossly normal, normal life span | no abnormal phenotype | Charbonneau et al. (2010a) | |
NPS | del 10 bp of exon/intron 65 border | C57BL/6 | Extreme leanness, reduced appetite | dominant | Marfan-progeroid-lipodystrophy syndrome | Duerrschmid et al. (2017) |
Tg(WT) | YAC including the whole wild type human FBN1 | C57BL/6J | Production of human fibrillin-1 at normal level in addition to mouse fibrillin-1 | no abnormal phenotype | NA | Judge et al. (2004) |
Tg(mut3) | YAC including human FBN1 carrying p.C1663R | C57BL/6J | Production of mutant human fibrillin-1 at 2 × normal level in addition to mouse fibrillin-1 | no abnormal phenotype | NA | Judge et al. (2004) |
List derived from the Mouse Genome Informatics (MGI) database (http://www.informatics.jax.org/allele/summary? markerId=MGI:95489) and relevant publications. As with the human condition, the dominant phenotype (expressed in heterozygotes) is less severe than the phenotype of homozygous or biallelic genotypes. See also Charbonneau et al. (2010a) and Hubmacher and Reinhardt (2011) for earlier summaries of available mouse variants. A number of conditional mutations in the Fbn1 locus have also been created (for example, Cook et al. 2012); these are not listed here as they do not replicate the human situation where the variant is present in all cells and tissues.
del, deletion; ins, insertion; dup, duplication; MFS, Marfan syndrome; SSS, stiff-skin syndrome; WMS, Weill-Marchesani syndrome; E8, embryonic day 8; E13, embryonic day 13; P7, postnatal day 7; P10, postnatal day 10; bp, base pairs; kb, kilobases.
a The MGI database lists C1037G and C1039G as synonyms for C1041G (https://www.informatics.jax.org/allele/MGI:3690325).